IHS Chemical Week

World News and Views :: Top of the News

Abbott to acquire Latin American generic drugs producer CFR for $3 billion

11:59 AM MDT | May 19, 2014 | Natasha Alperowicz

Abbott Laboratories said on Friday that it has signed a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals (Santiago), more than doubling the former's Latin American branded generics pharmaceutical presence and further expanding its presence in fast-growing markets. Abbott, under the terms of the agreement, will acquire the holding company that indirectly owns approximately 73% of CFR and will conduct a public cash tender offer for all of the outstanding CFR shares. The total purchase price, assuming all publicly held shares...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa